Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: India's Jubilant Pharmova March-Quarter Consol Net Profit Falls

June 4 (Reuters) - Jubilant Pharmova Ltd  JUBA.NS :
    * MARCH-QUARTER CONSOL NET PROFIT 2.14 BILLION RUPEES VERSUS
2.60
BILLION RUPEES YEAR AGO
    * MARCH-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 15.80
BILLION
RUPEES VERSUS 15.69 BILLION RUPEES YEAR AGO
    * RECOMMENDED DIVIDEND OF 5 RUPEES/SHARE
    * EXPECT TO INCUR CAPEX OF 7 BILLION - 8 BILLION RUPEES IN
FY22

Further company coverage:  JUBA.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news